Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.13, read 2026-11-01
Ethical passes the values gate
Price1,211.63 USD
Fair value1,049.02
Ethical score87.7/100
RatingOVERVALUED
Our investment reviews on this name
2026-10-24Read Distribution1,249.20-3.0% to today ✓Markdown gives way to Distribution first Distribution read since July
2026-10-22Read Markdown1,249.20-3.0% to today ✓Markup gives way to Markdown after a 9% slide in 11 days
2026-10-11Read Markup1,367.43-11.4% to today Accumulation gives way to Markup
2026-08-30Read Accumulation1,310.60-7.6% to today Distribution gives way to Accumulation after a 12% slide in 8 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Monolithic Power Systems holds its Distribution at $1,211.63. Consolidating, no directional conviction, held for 28 days.
As held on the ledger · 2026-10-30
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 28 days
Price at the screen
$1,211.63
Valuation
72.92 trailing · 33.99 forward price to earnings
Values screen
PASS· score 87.7
Beta
1.68
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
0.48%
Below 33%
Interest-bearing debt is just 0.5% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
3.75%
Below 33%
Cash held in interest-bearing accounts and securities is 3.7% of assets, under the one-third limit.
Pass
Receivables
32.30%
Below 49%
Money owed to the company is 32.3% of assets, under the 49% limit.
Pass
Revenue purity
1.04%
Below 5%
Only 1.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Monolithic Power Systems clears all five screens. Its business is in a permissible area, its debt is near-nil, and interest is about 1% of its income, under the ~5% line, so it passes.
Read as at 2026-11-01. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when MPWR's ethical verdict changes
Today MPWR passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads OVERVALUED: it trades above our $1,049.02 fair value estimate, moderate competitive moat, 47.60% revenue growth.
Fair value range in USD, drawn from the 2026-10-30 screen. The gold marker is the market price at the same screen. The price runs 13.4% above the base estimate.
Third-party analyst targets: 15 covering, consensus Strong Buy. The average target sits +49% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Where our models see it going: fair-value estimate $1,049.02, with a range of $1,049.02 to $1,206.37, dated to the 2026-10-30 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Power chip firm priced beyond its cycle
Picture a supplier of voltage converters riding strong demand from data centres and cars. Monolithic Power Systems shows 26% revenue growth, 23% margins and 20% ROE, yet our fair value sits 21% below the current price and the forward multiple stands at 42.9 times. The market loves the story and the analyst target of 1805 dollars, but the numbers point to a clear overvaluation.
This is a cyclical semiconductor business. Peak earnings often coincide with the lowest multiples, yet here the multiple is already stretched. A moderate moat offers some protection, yet any slowdown in end markets would compress both growth and the rating quickly.
The ethical screen is passed with no red flags. Even so the valuation leaves little room for the normal swings of the cycle. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
MPWR trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-29Distribution$1,211.22-3.0%Entry 22
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading oversold. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (14 analysts) rates it none, with a mean price target of $1797. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Distribution$1,249.20+0.0%Entry 21
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading oversold. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (14 analysts) rates it none, with a mean price target of $1797. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Distribution$1,249.20+0.0%Entry 20
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading oversold. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (14 analysts) rates it none, with a mean price target of $1797. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Distribution$1,249.20+0.0%Entry 19
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading oversold. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (14 analysts) rates it none, with a mean price target of $1797. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Distribution$1,249.20+0.0%Entry 18
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 7% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (14 analysts) rates it none, with a mean price target of $1797. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 7% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (14 analysts) rates it none, with a mean price target of $1797. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Markdown$1,249.20+0.0%Entry 16
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 7% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (14 analysts) rates it none, with a mean price target of $1797. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 7% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (14 analysts) rates it none, with a mean price target of $1797. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Markup$1,249.20-8.6%Entry 14
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 8.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 54% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (14 analysts) rates it none, with a mean price target of $1797.
2026-10-11Markup · changed$1,367.43+0.0%Entry 13
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 54% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (14 analysts) rates it none, with a mean price target of $1797.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
